Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin

被引:79
|
作者
Song, JH
Hiramatsu, K
Suh, JY
Ko, KS
Ito, T
Kapi, M
Kiem, S
Kim, YS
Won, SH
Peck, KR
Lee, NY
机构
[1] Sungkyunkwan Univ, ARFID, Div Infect Dis, Samsung Med Ctr,Kangnam Ku, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, ARFID, Dept Lab Med, Samsung Med Ctr,Kangnam Ku, Seoul 135710, South Korea
[3] Chungnam Natl Univ Hosp, Taejon, South Korea
[4] Juntendo Univ, Dept Bacteriol, Tokyo, Japan
关键词
D O I
10.1128/AAC.48.12.4926-4928.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To investigate the prevalence of Staphylococcus aureus with reduced susceptibility to vancomycin among methicillin-resistant S. aureus (MRSA) strains in Asian countries, a total of 1,357 clinical isolates of MRSA collected from 12 Asian countries were screened by using brain heart infusion agar plates containing 4 mg of vancomycin per liter. The presence of strains that were heterointermediately resistant to vancomycin (hVISA) was confirmed by population analysis. Of 347 (25.6%) MRSA isolates that grew on the screening agar plates, 58 isolates (4.3%) were hVISA. hVISA strains were found in India, South Korea, Japan, the Philippines, Singapore, Thailand, and Vietnam. However, neither vancomycin-intermediate S. aureus nor vancomycin-resistant S. aureus isolates were found among MRSA isolates from Asian countries in this survey.
引用
收藏
页码:4926 / 4928
页数:3
相关论文
共 50 条
  • [1] Reduced Susceptibility to Vancomycin in Staphylococcus aureus
    Mimica, Marcelo J.
    EMERGING INFECTIOUS DISEASES, 2011, 17 (11) : 2083 - 2084
  • [2] Staphylococcus aureus with reduced susceptibility to vancomycin
    Cosgrove, SE
    Carroll, KC
    Perl, TM
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 539 - 545
  • [3] Reduced Susceptibility to Vancomycin in Staphylococcus aureus Response
    Maria Aguado, Jose
    San-Juan, Rafael
    Lalueza, Antonio
    Sanz, Francisca
    Rodriguez-Otero, Joaquin
    Gomez-Gonzalez, Carmen
    Chaves, Fernando
    EMERGING INFECTIOUS DISEASES, 2011, 17 (11) : 2084 - 2084
  • [4] Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin
    Woods, CW
    Cheng, AC
    Fowler, VG
    Moorefield, M
    Frederick, J
    Sakoulas, G
    Meka, VG
    Tenover, FC
    Zwadyk, P
    Wilson, KH
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (08) : 1188 - 1191
  • [5] Staphylococcus aureus with reduced susceptibility to vancomycin in a dialysis graft
    Perla, RJ
    Knutson, EL
    Fontana, JL
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (04) : 566 - 567
  • [6] Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany
    Bierbaum, G
    Fuchs, K
    Lenz, W
    Szekat, C
    Sahl, HG
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) : 691 - 696
  • [7] Presence of Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Germany
    G. Bierbaum
    K. Fuchs
    W. Lenz
    C. Szekat
    H. -G. Sahl
    European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 : 691 - 696
  • [8] Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus
    Rishishwar, Lavanya
    Kraft, Colleen S.
    King Jordan, I.
    MSPHERE, 2016, 1 (04)
  • [9] Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin
    Wong, SSY
    Ng, TK
    Yam, WC
    Tsang, DNC
    Woo, PCY
    Fung, SKS
    Yuen, KY
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (04) : 261 - 268
  • [10] An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus
    Patel, JB
    Jevitt, LA
    Hageman, J
    McDonald, LC
    Tenover, FC
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) : 1652 - 1653